Stress test and treatment of chronic kidney disease
US11883371B2 · kind B2 · utility
1Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 23, 2021 |
| Grant date | Jan 30, 2024 |
| Priority date | — |
| Expiry date | Jun 17, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/7009
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention involves a novel method for treatment of chronic kidney disease comprising administering a compound that induces a stress protein response in a patient, and administering a potent antioxidant if the patent's response is below a predefined level. It also involves a quantitative measure for determining a patient's antioxidant reserve capacity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.